Identification of circulating tumor cells (CTC) in liquid biopsies opens a window of opportunities for the optimization of clinical management of oncologic patients. In ovarian cancer (OC), which involves atypical routes of metastatic spread, CTC analyses may also offer novel insights about the mechanisms behind malignant progression of the disease. However, current methodologies struggle to precisely define CTC number in the peripheral blood of OC patients, and the isolation of viable cells for further characterization is still challenging. The biggest limitation is the lack of methodological standardization for OC CTC detection, preventing comprehensive definition of their clinical potential required for the transfer to practice. Here we describe and compare methods for CTC analysis that have been implemented for OC thus far, discussing pros, cons and improvements needed. We identify biophysical separation approaches as optimal for CTC enrichment. On the other hand, the identification of specific tumor antigens or gene transcripts, despite displaying drawbacks related to tumor heterogeneity, still remains the best approach for OC CTC detection.

Lemma, S., Perrone, A.M., De Iaco, P., Gasparre, G., Kurelac, I. (2021). Current methodologies to detect circulating tumor cells: a focus on ovarian cancer. AMERICAN JOURNAL OF CANCER RESEARCH, 11(9), 4111-4126.

Current methodologies to detect circulating tumor cells: a focus on ovarian cancer

Lemma, Silvia;Perrone, Anna M;De Iaco, Pierandrea;Gasparre, Giuseppe;Kurelac, Ivana
2021

Abstract

Identification of circulating tumor cells (CTC) in liquid biopsies opens a window of opportunities for the optimization of clinical management of oncologic patients. In ovarian cancer (OC), which involves atypical routes of metastatic spread, CTC analyses may also offer novel insights about the mechanisms behind malignant progression of the disease. However, current methodologies struggle to precisely define CTC number in the peripheral blood of OC patients, and the isolation of viable cells for further characterization is still challenging. The biggest limitation is the lack of methodological standardization for OC CTC detection, preventing comprehensive definition of their clinical potential required for the transfer to practice. Here we describe and compare methods for CTC analysis that have been implemented for OC thus far, discussing pros, cons and improvements needed. We identify biophysical separation approaches as optimal for CTC enrichment. On the other hand, the identification of specific tumor antigens or gene transcripts, despite displaying drawbacks related to tumor heterogeneity, still remains the best approach for OC CTC detection.
2021
Lemma, S., Perrone, A.M., De Iaco, P., Gasparre, G., Kurelac, I. (2021). Current methodologies to detect circulating tumor cells: a focus on ovarian cancer. AMERICAN JOURNAL OF CANCER RESEARCH, 11(9), 4111-4126.
Lemma, Silvia; Perrone, Anna M; De Iaco, Pierandrea; Gasparre, Giuseppe; Kurelac, Ivana
File in questo prodotto:
File Dimensione Formato  
ajcr0136241.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale (CCBYNC)
Dimensione 581.41 kB
Formato Adobe PDF
581.41 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/835466
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 5
social impact